patients with iddm determined to have inadequate glucose counterregulation during an insulin infusion test ( 40 mu x kg-1 x h-1 ) with bedside plasma glucose monitoring and clinical observation have been found to have a 25-fold greater risk of severe hypoglycemia during subsequent intensive therapy than patients with adequate glucose counterregulation .
C0020615
hypoglycemia
C0017725
glucose